{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:51:22Z","timestamp":1771048282025,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jdin.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:14:52Z","timestamp":1671826492000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Risk factors and drugs that trigger the onset of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: A population-based cohort study using the Shizuoka Kokuho database"],"prefix":"10.1016","volume":"11","author":[{"given":"Nanako","family":"Ubukata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatoko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdin.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","article-title":"A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children","volume":"24","author":"Stevens","year":"1922","journal-title":"Am J Dis Child"},{"issue":"11","key":"10.1016\/j.jdin.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis: an eruption resembling scalding of the skin","volume":"68","author":"Lyell","year":"1956","journal-title":"Br J Dermatol"},{"issue":"968","key":"10.1016\/j.jdin.2022.12.002_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/pgmj.2005.042952","article-title":"Colonic involvement in Stevens-Johnson syndrome","volume":"82","author":"Powell","year":"2006","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation","volume":"42","author":"de Prost","year":"2014","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jdin.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/BCR.0000000000000006","article-title":"Mesenteric ischemia secondary to toxic epidermal necrolysis","volume":"35","author":"Pradka","year":"2014","journal-title":"J Burn Care Res"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J Dermatol Sci"},{"issue":"11","key":"10.1016\/j.jdin.2022.12.002_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance Database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/epi.16751","article-title":"Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: a nationwide study using health claims data in Korea","volume":"62","author":"Chung","year":"2021","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.jdin.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40257-021-00661-0","article-title":"Culprit medications and risk factors associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: population-based Nested case-control study","volume":"23","author":"Gronich","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"24","key":"10.1016\/j.jdin.2022.12.002_bib10","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"19","key":"10.1016\/j.jdin.2022.12.002_bib12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jdin.2022.12.002_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jdin.2022.12.002_bib14","first-page":"47","article-title":"Epidemiology of SJS\/TEN","volume":"307","author":"Sueki","year":"2021","journal-title":"MB Derma"},{"issue":"5","key":"10.1016\/j.jdin.2022.12.002_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","article-title":"Immune checkpoint inhibitor-related dermatologic adverse events","volume":"83","author":"Geisler","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2188\/jea.JE20200480","article-title":"Data resource profile of Shizuoka Kokuho Database (SKDB) using integrated health- and care-insurance claims and health checkups: the Shizuoka study","volume":"32","author":"Nakatani","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jdin.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdin.2020.10.011","article-title":"Late-onset development of psoriasis in Japan: a population-based cohort study","volume":"2","author":"Goto","year":"2021","journal-title":"JAAD Int"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac009","article-title":"Assessment of coding-based frailty algorithms for long-term outcome prediction among older people in community settings: a cohort study from the Shizuoka Kokuho Database","volume":"51","author":"Nishimura","year":"2022","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jdermsci.2022.02.006","article-title":"A new susceptibility index to predict the risk of severe herpes zoster-associated pain: a Japanese regional population-based cohort study, the Shizuoka study","volume":"105","author":"Hashizume","year":"2022","journal-title":"J Dermatol Sci"},{"issue":"11","key":"10.1016\/j.jdin.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.alit.2021.01.004","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: matched case\u2013control and cohort studies","volume":"70","author":"Fukasawa","year":"2021","journal-title":"Allergol Int"},{"issue":"6","key":"10.1016\/j.jdin.2022.12.002_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"14","key":"10.1016\/j.jdin.2022.12.002_bib23","first-page":"2732","article-title":"Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs","volume":"19","author":"Ordo\u00f1ez","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"10106","key":"10.1016\/j.jdin.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jdin.2022.12.002_bib26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"issue":"245","key":"10.1016\/j.jdin.2022.12.002_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008227","article-title":"An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions","volume":"6","author":"Saito","year":"2014","journal-title":"Sci Transl Med"},{"issue":"600","key":"10.1016\/j.jdin.2022.12.002_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2398","article-title":"Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"13","author":"Kinoshita","year":"2021","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.jdin.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1172\/JCI136466","article-title":"DCAF1 regulates Treg senescence via the ROS axis during immunological aging","volume":"130","author":"Guo","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jdin.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jnr.10766","article-title":"Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity","volume":"74","author":"Tsaknaridis","year":"2003","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.jdin.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.alit.2022.02.001","article-title":"Drug allergy and autoimmune diseases","volume":"71","author":"Watanabe","year":"2022","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.jdin.2022.12.002_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000500945","article-title":"Severe cutaneous adverse reactions during tapering of high-dose systemic steroid therapy for autoimmune diseases: implications for non-HIV immune reconstitution inflammatory syndrome","volume":"11","author":"Sueki","year":"2019","journal-title":"Case Rep Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jdermsci.2017.06.013","article-title":"Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization","volume":"87","author":"Rausch","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40425-018-0493-9","article-title":"\u03b1-PD-1 therapy elevates Treg\/Th balance and increases tumor cell pSmad3 that are both targeted by \u03b1-TGF\u03b2 antibody to promote durable rejection and immunity in squamous cell carcinomas","volume":"7","author":"Dodagatta-Marri","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jdin.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.003","article-title":"Treg-mediated acquired resistance to immune checkpoint inhibitors","volume":"457","author":"Saleh","year":"2019","journal-title":"Cancer Lett"},{"issue":"32","key":"10.1016\/j.jdin.2022.12.002_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200879119","article-title":"An anti-CTLA-4 heavy chain-only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile","volume":"119","author":"Gan","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdin.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2019.01.006","article-title":"Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis","volume":"64","author":"Kumar","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.jdin.2022.12.002_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaad.2020.09.054","article-title":"Cutaneous adverse events caused by immune checkpoint inhibitors","volume":"85","author":"Quach","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejca.2020.12.018","article-title":"Immune checkpoint inhibitor\u2013related epidermal necrolysis: a rare condition with poor prognosis","volume":"145","author":"He","year":"2021","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jdin.2022.12.002_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/CJI.0000000000000302","article-title":"Combination therapy of ipilimumab and Nivolumab-associated toxic epidermal necrolysis (TEN) in a patient with metastatic melanoma: a case report and literature review","volume":"43","author":"Logan","year":"2020","journal-title":"J Immunother"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clindermatol.2019.10.015","article-title":"The life-threatening eruptions of immune checkpoint inhibitor therapy","volume":"38","author":"Coleman","year":"2020","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"13","author":"Tohkin","year":"2013","journal-title":"Pharmacogenomics J"},{"issue":"15","key":"10.1016\/j.jdin.2022.12.002_bib43","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"12","key":"10.1016\/j.jdin.2022.12.002_bib44","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"HLA-B\u22171511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jdin.2022.12.002_bib45","doi-asserted-by":"crossref","first-page":"45553","DOI":"10.1038\/srep45553","article-title":"HLA-B\u221715:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis","volume":"7","author":"Jaruthamsophon","year":"2017","journal-title":"Sci Rep"},{"issue":"7404","key":"10.1016\/j.jdin.2022.12.002_bib46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jdin.2022.12.002_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p-i concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol Int"},{"issue":"6982","key":"10.1016\/j.jdin.2022.12.002_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"A marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jdin.2022.12.002_bib49","doi-asserted-by":"crossref","first-page":"827893","DOI":"10.3389\/falgy.2022.827893","article-title":"Risk assessment in drug hypersensitivity: detecting small molecules which outsmart the immune system","volume":"3","author":"Pichler","year":"2022","journal-title":"Front Allergy"},{"issue":"10","key":"10.1016\/j.jdin.2022.12.002_bib50","first-page":"2234","article-title":"The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective","volume":"30","author":"Mockenhaupt","year":"2003","journal-title":"J Rheumatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722001596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722001596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:41Z","timestamp":1762981241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328722001596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S2666328722001596"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2022.12.002","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and drugs that trigger the onset of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: A population-based cohort study using the Shizuoka Kokuho database","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}